Consult an Expert
Trademark
Design Registration
Consult an Expert
Trademark
Copyright
Patent
Infringement
Design Registration
More
Consult an Expert
Consult an Expert
Trademark
Design Registration
Login
/
CILIVENIC 625 (1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla
C
CILIVENIC 625
(1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla
CILIVENIC 625 is a Trademark filed on Feb 15, 2019 in through IP Office.The Trademark is registered to (1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla and was filed by attorney.
C
CILIVENIC 625 (1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla Trademark Information
Application ID
4089336
Status
Registered
Date of Application
Feb 15, 2019
Classes
5
Proprietor(s)
(1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla
Valid/Upto
15/02/2029
FAQ's for CILIVENIC 625 (1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla Trademark
The application for CILIVENIC 625 was made on Feb 15, 2019
The trademark applicant for CILIVENIC 625 is (1) M/S REMONENT PHARMACEUTICALSPartnership Firm Details : Ajay Badhwar, Naman Srivastav & Amresh Kumar Shukla.
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Registered.
Listed application Id of CILIVENIC 625 is 4089336.
CILIVENIC 625 Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
Don’t lose your brand like ””
Our experts are here to assist you in finding a similar trademark.
Our experts are here to assist you in finding a similar trademark.
4.5
(18k+ reviews)
1 Lakh+
TM Registered since 2011
